Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, 63225, Langen, Germany.
Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, 63225, Langen, Germany.
Biomaterials. 2017 Nov;144:84-94. doi: 10.1016/j.biomaterials.2017.07.032. Epub 2017 Jul 25.
We have established a novel approach for the covalent coupling of large polypeptides to the surface of fully assembled adeno-associated viral gene transfer vector (AAV) particles via split-intein mediated protein-trans-splicing (PTS). This way, we achieved selective gene transfer to distinct cell types. Single-chain variable fragments (scFvs) or designed ankyrin repeat proteins (DARPins), exhibiting high-affinity binding to cell surface receptors selectively expressed on the surface of target cells, were coupled to AAV particles harboring mutations in the capsid proteins which ablate natural receptor usage. Both, the AAV capsid protein VP2 and multiple separately produced targeting ligands recognizing Her2/neu, EpCAM, CD133 or CD30 were genetically fused with complementary split-intein domains. Optimized coupling conditions led to an effective conjugation of each targeting ligand to the universal AAV capsid and translated into specific gene transfer into target receptor-positive cell types in vitro and in vivo. Interestingly, PTS-based AAVs exhibited significantly less gene transfer into target receptor-negative cells than AAVs displaying the same targeting ligand but coupled genetically. Another important consequence of the PTS technology is the possibility to now display scFvs or other antibody-derived domain formats harboring disulfide-bonds in a functionally active form on the surface of AAV particles. Hence, the custom combination of a universal AAV vector particle and targeting ligands of various formats allows for an unprecedented flexibility in the generation of gene transfer vectors targeted to distinct cell types.
我们建立了一种新的方法,通过分裂内含肽介导的蛋白质转剪接(PTS)将大的多肽共价偶联到完全组装的腺相关病毒基因转移载体(AAV)颗粒的表面。通过这种方式,我们实现了对不同细胞类型的选择性基因转移。单链可变片段(scFv)或设计的锚蛋白重复蛋白(DARPin),对靶细胞表面选择性表达的细胞表面受体具有高亲和力结合,与衣壳蛋白发生突变的 AAV 颗粒偶联,这些突变会消除天然受体的使用。AAV 衣壳蛋白 VP2 和多个分别识别 Her2/neu、EpCAM、CD133 或 CD30 的靶向配体,都与互补的分裂内含肽结构域进行了基因融合。优化的偶联条件导致每个靶向配体有效地偶联到通用的 AAV 衣壳上,并转化为在体外和体内对靶受体阳性细胞类型的特异性基因转移。有趣的是,与遗传偶联的 AAV 相比,基于 PTS 的 AAV 显示出对靶受体阴性细胞的基因转移显著减少。PTS 技术的另一个重要后果是现在可以在 AAV 颗粒表面以功能活性形式展示含有二硫键的 scFv 或其他抗体衍生的结构域格式。因此,通用 AAV 载体颗粒与各种形式的靶向配体的定制组合允许针对不同细胞类型的基因转移载体的产生具有前所未有的灵活性。